Development of Stabilizing Formulations of a Trivalent Inactivated Poliovirus Vaccine in a Dried State for Delivery in the Nanopatch™ Microprojection Array.

"This work was supported financially by World Health Organization. The authors would like to acknowledge Bilthoven Biologicals, Cyrus Poonawalla Group, Netherlands for the supply of the 3 IPV bulk antigens, Cyrus Technology Pte Ltd (Singapore) for supplying the LCP discs, and Vaxxas staff/consultants including Christopher Flaim, Neil Harris, and David Muller. They also wish to acknowledge the assistance of Harshit Khasa and Kelly Schwinghamer during initial formulation experiments at KU."

"This work was supported financially by World Health Organization. The authors would like to acknowledge Bilthoven Biologicals, Cyrus Poonawalla Group, Netherlands for the supply of the 3 IPV bulk antigens, Cyrus Technology Pte Ltd (Singapore) for supplying the LCP discs, and Vaxxas staff/consultants including Christopher Flaim, Neil Harris, and David Muller. They also wish to acknowledge the assistance of Harshit Khasa and Kelly Schwinghamer during initial formulation experiments at KU."